Markets /Healthcare /GRFS Grifols, S.A. GRFS Full chart Compare Add to watchlist Set alert Price alert · GRFS Alert when the price is Price abovePrice below Price level Set alert All alert types 8.15 USD -0.05 (-0.61%) Regular-session close 8.14 -0.01 -0.12% After hours · Nov 20, 4:31 PM ET 8.08 Day range 8.22 7.02 52-week range 9.72 YTD -12.83%1 year -3.32% Overview Chart ChartPrice historyFinancials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts News All sources Benzinga only 4 days ago benzinga.com Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease Grifols ((MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading producer of plasma-derived medicines, today presents new real-world evidence (RWE) data from the AMBAR® (Alzheimer…